RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION:

# Drug Count
0 CERTOLIZUMAB PEGOL 4
1 CANDESARTAN CILEXETIL 2
2 METHOTREXATE 2
3 METHOTREXATE SODIUM 2
4 NIRSEVIMAB 2
5 RELUGOLIX 2
6 ROSUVASTATIN 2
7 TADALAFIL 2
8 ALBUTEROL SULFATE 1
9 ATORVASTATIN CALCIUM 1
See all common drugs associated with RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION

RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIRSEVIMAB 2 0.0011
1 PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION 1 0.0008
2 PILOCARPINE HYDROCHLORIDE 1 0.0004
3 CEVIMELINE HYDROCHLORIDE 1 0.0004
4 CANDESARTAN CILEXETIL 2 0.0001
5 BIMEKIZUMAB 1 0.0000
6 ROSUVASTATIN 2 0.0000
7 TADALAFIL 2 0.0000
8 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 1 0.0000
9 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 1 0.0000
See all drugs enriched for association with RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION